首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   685篇
  免费   115篇
  国内免费   28篇
耳鼻咽喉   7篇
儿科学   4篇
基础医学   124篇
口腔科学   210篇
临床医学   31篇
内科学   63篇
皮肤病学   2篇
神经病学   1篇
特种医学   3篇
外科学   140篇
综合类   75篇
预防医学   13篇
药学   82篇
中国医学   35篇
肿瘤学   38篇
  2024年   1篇
  2023年   31篇
  2022年   19篇
  2021年   33篇
  2020年   27篇
  2019年   19篇
  2018年   28篇
  2017年   31篇
  2016年   37篇
  2015年   35篇
  2014年   47篇
  2013年   68篇
  2012年   35篇
  2011年   34篇
  2010年   48篇
  2009年   45篇
  2008年   48篇
  2007年   43篇
  2006年   30篇
  2005年   18篇
  2004年   28篇
  2003年   26篇
  2002年   23篇
  2001年   16篇
  2000年   3篇
  1999年   2篇
  1998年   9篇
  1997年   6篇
  1996年   8篇
  1995年   9篇
  1994年   4篇
  1993年   4篇
  1992年   1篇
  1990年   4篇
  1989年   3篇
  1986年   1篇
  1985年   1篇
  1982年   1篇
  1980年   1篇
  1977年   1篇
排序方式: 共有828条查询结果,搜索用时 31 毫秒
1.
目的 慢性牙周炎表现的病理性骨吸收非常常见,牙周膜干细胞(PDLSCs)的外泌体(Exo)对骨吸收的作用和影响尚不明确,本研究分析了该Exo蛋白组分对破骨细胞分化的影响。方法 分别从正畸前拔牙患者和慢性牙周炎患者的牙周膜组织中提取PDLSCs,通过流式细胞术检测表面标记物;通过差速离心分别提取2种细胞的Exo,即Exo-WT和Exo-CP,并通过Western blot、透射电子显微镜(TEM)、蛋白浓度检测、纳米粒径追踪检测Exo特征;通过蛋白质谱检测2种Exo的蛋白组分;通过酶联免疫吸附(ELISA)验证了差异表达蛋白肿瘤坏死因子α(TNF-α)、核因子κB受体活化因子配体(RANKL)、白细胞介素(IL)-1α、转化生长因子β(TGF-β)、骨形态发生蛋白2(BMP-2)表达水平;将10、100、1 000 μg·mL-1的Exo-CP或Exo-WT加入RAW264.7培养基中并于5 d时通过实时荧光定量聚合酶链反应(RT-qPCR)、Western blot、抗酒石酸酸性磷酸酶(TRAP)染色检测破骨分化相关指标表达情况;采用SPSS 24.0软件对实验数据进行统计学分析。结果 Exo-CP富集的差异表达蛋白主要与破骨细胞分化的TNF信号通路、核转录因子κB(NF-κB)信号通路相关;ELISA实验证实了Exo-CP中高表达TNF-α、RANKL、IL-1α,低表达TGF-β1、BMP-2(P<0.05);Exo-CP作用于RAW264.7,显著提高了细胞的破骨分化相关基因及蛋白的表达水平,TRAP染色可见分化的破骨细胞,且呈现浓度依赖性,100、1 000 μg·mL-1浓度Exo-CP对破骨细胞分化的促进作用显著高于10 μg·mL-1浓度组(P<0.05)。结论 慢性牙周炎的病理性骨吸收可能由炎性PDLSCs所分泌的Exo通过促进破骨细胞分化引起,Exo中主要的作用蛋白可能为RANKL和TNF-α,本研究为慢性牙周炎骨吸收的发病机制提供了新视角。  相似文献   
2.
长期以来的研究表明先天免疫和后天免疫在宿主抵御外来微生物入侵的过程中起着至关重要的作用,而在这过程中也会同时造成宿主自身的组织或器官的损害。骨骼系统就是其中之一,在一些诸如类风湿性关节炎、牙周炎等疾病中,免疫系统的反应不仅起到去除外来致病菌的作用,还会同时造成骨骼系统的破坏。长期以来大部分的研究都致力于了解免疫系统对骨组织破坏的机制,而近些年来有研究开始探究骨反作用于免疫系统,由此衍生出了一个全新的研究领域——骨免疫。文章从骨免疫的机制、免疫与骨吸收作用通路以及在口腔相关疾病的作用机制等方面总结了近些年来相关的研究进展。  相似文献   
3.
《Diagnostic Histopathology》2022,28(12):522-533
Neoplasms of bone with numerous non-neoplastic osteoclast type giant cells are relatively common and exhibit diverse phenotypes of the neoplastic cells. These tumors have a broad spectrum of biological potential which necessitates accurate recognition and diagnosis. Their clinicopathological features are overlapping, therefore, immunohistochemistry and molecular studies may be required for evaluation. Correlation with imaging studies provides additional information that should be incorporated into the pathological interpretation.  相似文献   
4.
In osteoimmunology, osteoclastogenesis is understood in the context of the immune system. Today, the in vitro model for osteoclastogenesis necessitates the addition of recombinant human receptor activator of nuclear factor kappa‐B ligand (RANKL) and macrophage colony‐stimulating factor (M‐CSF). The peripheral joints of patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) are characterized by an immune‐mediated inflammation that can lead to bone destruction. Here, we evaluate spontaneous in vitro osteoclastogenesis in cultures of synovial fluid mononuclear cells (SFMCs) activated only in vivo. SFMCs were isolated and cultured for 21 days at 0.5–1.0 × 106 cells/mL in culture medium. SFMCs and healthy control peripheral blood monocytes were cultured with RANKL and M‐CSF as controls. Tartrate‐resistant acid phosphatase (TRAP) positive multinucleated cells were found in the SFMC cultures after 21 days. These cells expressed the osteoclast genes calcitonin receptor, cathepsin K, and integrin β3, formed lacunae on dentin plates and secreted matrix metalloproteinase 9 (MMP9) and TRAP. Adding RANKL and M‐CSF potentiated this secretion. In conclusion, we show that SFMCs from inflamed peripheral joints can spontaneously develop into functionally active osteoclasts ex vivo. Our study provides a simple in vitro model for studying inflammatory osteoclastogenesis.  相似文献   
5.
6.
《Journal of endodontics》2019,45(7):890-897
IntroductionThe aim was to assess the association of inducible costimulator (ICOS) and ICOS ligand with bone destruction in apical periodontitis (AP).MethodsSpecimens from patients presenting with AP were obtained during apicoectomy and subjected to histopathologic analysis and molecular assessment of ICOS/ICOS ligand. In addition, the experimental AP was induced by exposing the pulp of first mandibular molars of rats. Histologic and radiographic examinations were performed to validate the periapical lesions. The immunolocalization and messenger RNA expression of ICOS/ICOS ligand were evaluated by immunofluorescence staining and quantitative real-time polymerase chain reaction. The osteoclastic activities in periapical lesions, including the lesion size and the expression of tartrate-resistant acid phosphatase and the receptor activator of nuclear factor kappa B ligand, were recorded and followed by correlation analysis with ICOS/ICOS ligand expression.ResultsIn excisional specimens from AP patients, a significantly increased expression of ICOS/ICOS ligand was found compared with the healthy control. In the experimental AP samples, the expression of ICOS/ICOS ligand, tartrate-resistant acid phosphatase, and receptor activator of nuclear factor kappa B ligand was significantly elevated in inflamed periapical tissues (AP group) when compared with the healthy control. The number of ICOS+/ICOS ligand+ cells was highly correlated with the periapical lesion size (r = 0.892, P < .01 and r = 0.930, P < .01, respectively).ConclusionsThe increased expression of ICOS/ICOS ligand in periapical lesions was associated with the inflammatory infiltration and alveolar bone destruction of AP.  相似文献   
7.
Rutaecarpine is a major alkaloid isolated from Evodia rutaecarpa. Here, we investigated the effects of rutaecarpine on osteoclast differentiation induced by macrophage colony stimulating factor (M‐CSF) and receptor activator of nuclear factor κ‐B ligand (RANKL) in bone marrow‐derived macrophages (BMMs). Treatment with rutaecarpine significantly inhibited osteoclastogenesis and prevented bone resorption of BMM‐derived osteoclasts. Mechanistically, rutaecarpine decreased the protein level of nuclear factor of activated T cells cytoplasmic‐1 (NFATc1) and the phosphorylation of other signalling pathways during the osteoclast differentiation. Thus, rutaecarpine may be useful as a therapeutic agent for the treatment of bone diseases.  相似文献   
8.
金属蛋白酶解离素28(a disintegrin and metallo2 proteinase 28,ADAM28)是ADAM家族最近发现的一种分泌性糖蛋白,它同样具有ADAM家族的生理功能:参与细胞增殖,分化,胞外基质重建,裂解基质蛋白和细胞迁移等。研究显示,ADAM28基因参与了牙胚的发育过程,并在牙源性间充质细胞的增殖、分化和凋亡中发挥重要的调控作用。同时ADAM28基因具有金属蛋白酶活性,因而它对于细胞外基质的形成和蛋白的外功能区脱落有重要的调节作用。本文着重回顾了近年来国内外关于ADAM28生物学功能的研究及其在牙齿发育中的作用机制。  相似文献   
9.
BACKGROUND AND OBJECTIVE: Enamel matrix derivative (EMD) is used clinically to promote periodontal tissue regeneration, and it has been reported that EMD can induce the formation of osteoclasts in mouse marrow cultures. In the present study, we investigated the mechanisms of EMD-induced osteoclast formation using a mouse monocytic cell line, RAW 264.7. MATERIAL AND METHODS: Bioactive fractions were purified from EMD by reverse-phase HPLC using a C18 hydrophobic support, following which RAW 264.7 cells were cultured with EMD or its purified fractions in the presence of receptor activator of nuclear factor-kappaB ligand (RANKL) for 8 d. Following staining with tartrate-resistant acid phosphatase (TRAP), TRAP-positive multinucleated cells were counted. The expression of receptor activator of nuclear factor-kappaB (RANK), as well as phosphorylation of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein (MAP) kinase, in RAW 264.7 cells were detected using immunoblotting. To determine whether EMD has an effect on osteoclast function, differentiated RAW 264.7 cells were cultured on Osteologic Multitest slides with RANKL in the presence of EMD. RESULTS: Purified EMD fractions (fraction numbers 21-25; EMD peak 2) were found to enhance the formation and function of RAW 264.7 cells induced by RANKL. Moreover, EMD peak 2 enhanced the levels of phosphorylation of ERK p38 and RANK in RAW 264.7 cells stimulated with RANKL. CONCLUSION: Our results indicate that EMD induces the formation of osteoclasts through interaction with RANKL, while ERK and p38 MAPK may play a critical role in the enhancement of osteoclast formation in RAW 264.7 cells.  相似文献   
10.
Background Receptor activator of NF‐κB ligand (RANKL), a member of the tumor necrosis factor superfamily, is a key mediator of osteoclast formation, activation, and survival. Thus, it is reasonable to hypothesize that there might be a functional relationship between RANKL expression and peri‐implantitis. Purpose This pilot study was performed to determine the reference levels for soluble RANKL (sRANKL) in peri‐implant crevicular fluid and to correlate them with the clinical parameters associated with inflammatory reactions and bone destruction. Materials and Methods The clinical parameters probing depth (PD), modified bleeding index (MBI), and modified plaque index (MPI) served as indicators for bone resorption and inflammation. Exclusion criteria for calculations were the detection limit of the immunoassay and the minimum acceptable crevicular volume for measurement. From the 84 collected samples of 16 patients, 30–84 years of age, with a total of 19 implants, 29 met these criteria. The absolute amount of sRANKL within crevicular fluid adsorbed to filter strips was a median of 0.18 femtomol (fmol; range, 0.08–0.53) and 0.26 nM (range, 0.09–1.21) when normalized by volume. PD was 4 mm in median and varied within a range between 2 and 12 mm. Results Absolute amounts of sRANKL showed no correlation with the adsorbed volume and the clinical parameters PD, MBI, and MPI. When sRANKL was normalized by volume, no correlation with the clinical parameters PD, MBI, and MPI was observed either. The patients’ age was not associated with total sRANKL and the concentration of RANKL within crevicular fluid. Absolute levels of sRANKL and sRANKL concentration did not show any differences based on the sampling sites buccal and lingual, or on the patients’ gender. A significant difference in sRANKL concentration was detectable when samples from maxillary implants (0.31 nM median; range, 0.12–1.21) were compared with samples from mandibular implants (0.21 nM median; range, 0.09–0.6) (p=.03). Absolute levels of sRANKL were not different between the maxilla and the mandible. Conclusion Given the limited sample size, our data provide a basis for future prospective longitudinal studies on the possible relevance of sRANKL as a prognostic marker in peri‐implantitis, and for an understanding of the pathophysiologic process of the disease as a prerequisite for the design of treatment strategies.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号